Electronics maker Qisda Corp (佳世達) and TCI Co (大江生醫), which manufactures health food, functional beverages and skincare products, on Friday said that they would form a strategic alliance through a private placement.
Under the deal, Qisda plans to acquire 4.72 million shares in a TCI subsidiary, TCI Gene Inc (大江基因), at NT$115.5 per share, the company’s regulatory filing showed on Friday.
TCI Gene is mainly engaged in the research and manufacturing of various genetic testing, stem cell and immune cell products.
Photo: Chen Mei-ying, Taipei Times
The NT$545.16 million (US$18.38 million) investment would allow Qisda to hold a 17.84 percent stake in TCI Gene, using its own capital to fund the deal, the filing said.
“To strengthen the company’s biotechnology business, Qisda has stepped into the field of precision medicine,” the company said in the filing. “Through this investment, we will complement each other’s resources, expand the biotechnology and medical care business, and provide customers with a wider range of products and services.”
Qisda manufactures computer accessories, communication devices and consumer electronics. It also provides consulting and technical services, and has cultivated a high-value-added medical business, which has been the firm’s best performer during the COVID-19 pandemic.
Precision medicine is an emerging model in which precise detection prevents diseases in their early stages, and treats them with specific medicines. The practice provides treatment that most accurately minimizes adverse drug reactions and avoids wasting medical resources, it said.
A PricewaterhouseCoopers report on the precision health industry said that the market is forecast to grow from US$68.3 billion in 2020 to US$134.4 billion in 2025, with a compound annual growth rate of 14 percent.
The genetic testing market, which is the basis of precision medicine, has attracted much attention, Qisda said.
The market potential for this segment is predicted to grow from US$8 billion last year to US$15.8 billion in 2030, with compound growth of 7.6 percent, it said, citing data from Precedence Research.
The application of cell therapy in precision medicine should also have high growth potential, it added.
Precision medicine is an emerging business suitable for technology firms, as it is expected to integrate new technologies such as genetic testing, immune cell therapy and artificial intelligence, Qisda chairman Peter Chen (陳其宏) said.
“We look forward to providing more accurate preventive medicine, precise diagnosis and treatment services to the public through cooperation with TCI Group (大江生醫集團),” Chen said in a statement.
TCI Group chairman Vincent Lin (林詠翔) said he expects to leverage the strength of Qisda in medical services, equipment, pharmaceutical access and big data solutions to increase TCI Gene’s products and testing services.
British Prime Minister Rishi Sunak’s government should take steps to cut UK reliance on semiconductors from Taiwan because of the threat posed by China, a draft strategy said. Chinese interference or an invasion of Taiwan would threaten Britain’s economy, according to the unpublished strategy seen by Bloomberg. That is because it would compromise supplies to and from Taiwan, which is home to more than 90 percent of the manufacturing capacity for all leading-edge chips, including the world’s pre-eminent silicon foundry, Taiwan Semiconductor Manufacturing Co (台積電). The strategy is important because semiconductors are used in everything from cellphones to cars, and shortages have
BIG SPENDERS: China’s reopening is a key ‘mega-theme’ for the sector, RBC Bank said, but it remains to be seen how much Chinese tourists will buy The European luxury sector is welcoming the end of pandemic lockdowns in China, as the return of big-spending Chinese tourists could sustain further growth. Prior to the pandemic, Chinese tourists visiting Europe were a major source of sales for luxury houses. The Chinese accounted for “a third of luxury purchases in the world and two-thirds of those purchases were made outside China”, said Joelle de Montgolfier, head of the luxury division at management consulting firm Bain & Co. Their return has led RBC Bank to revise up its growth forecast for the sector this year to 11 percent, from 7 percent previously. “China
‘IT HURTS TOO MUCH’: After talks between Blizzard and NetEase over their contract broke down, servers hosting Blizzard’s games in China were shut down Millions of Chinese gamers have lost access to World of Warcraft after a furious dispute between US title owner Activision Blizzard Inc and NetEase Inc (網易), its longtime local partner in the world’s biggest gaming market. Devotees of the popular game took to social media networks to bemoan the loss, with one posting an image of a failed connection message accompanied by crying emojis. “It really hurts my heart,” one wrote. “It hurts, it hurts too much,” another said. Massively popular worldwide, particularly in the 2000s, World of Warcraft — often abbreviated as WoW — is an online multiplayer role-playing game set in
The US Department of Justice (DOJ) on Tuesday accused Alphabet Inc’s Google of abusing its dominance in digital advertising, threatening to dismantle a key business at the heart of one of Silicon Valley’s most successful Internet firms. The US government said Google should be forced to sell its ad manager suite, tackling a business that generated about 12 percent of Google’s revenues in 2021, but also plays a vital role in the search engine and cloud company’s overall sales. “Google has used anticompetitive, exclusionary, and unlawful means to eliminate or severely diminish any threat to its dominance over digital advertising technologies,” the